https://doi.org/10.4081/reumatismo.2021.1447
Quality of life measures in systemic lupus erythematosus: a systematic review
Submitted: 10 August 2021
Accepted: 12 January 2022
Published: 7 February 2022
Accepted: 12 January 2022
Abstract Views: 6881
PDF: 1480
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
In this study we systematically investigated the health-related quality of life (HRQoL) tools, which have been most often used over the last five years to evaluate the QoL in patients with systemic lupus erythematosus (SLE), focusing on their items and applications. A detailed literature search was conducted: the inclusion criteria were as follows: 1) studies including at least 50 patients; 2) studies including at least 25 patients with SLE; 3) quality of life testing with validated measures. The systematic review was based on 119 studies for a total of 32,449 SLE patients and 3092 controls. A total of 35 different patients-reported quality of life measures, applied in cohorts of patients with SLE, were retrieved with the 36-item Medical Outcome Short Form (SF-36) (63 studies of 119 =52.95%), Lupus Quality of Life (LupusQoL) (17 studies =14.3%) and Lupus Patient-Reported Outcome (LupusPRO) (12 studies =10%) being the most commonly used tools. Overall, this systematic review of the literature indicated that quality of life in patients with SLE appears to be poor and generally lower compared to both the general population and patients with other chronic conditions, as was shown by a few studies that used SF-36 and LupusPRO. The use of HRQoL scoring in SLE is gaining increasing interest and is used both in randomized controlled trials and in real-life. Future efforts are needed to improve the understanding of the impact of the disease burden on quality of life from the patient’s perspective.
Tsokos GC. Mechanisms of disease: Systemic lupus erythematosus. N Engl J Med. 2011 Dec;365(22):2110–21121.
DOI: https://doi.org/10.1056/NEJMra1100359
Kaul A, Gordon C, Crow MK, Touma Z, Urowitz MB, Van Vollenhoven R, et al. Systemic lupus erythematosus. Nat Rev Dis Prim [Internet]. 2016 Jun 16 [cited 2021 Feb 16];2(1):16039. Available from: www.nature.com/nrdp
DOI: https://doi.org/10.1038/nrdp.2016.39
Kernder A, Elefante E, Chehab G, Tani C, Mosca M, Schneider M. The patient’s perspective: Are quality of life and disease burden a possible treatment target in systemic lupus erythematosus? Rheumatol (United Kingdom). 2020;59:V63–8.
DOI: https://doi.org/10.1093/rheumatology/keaa427
Almehed K, Carlsten H, Forsblad-D’Elia H. Health-related quality of life in systemic lupus erythematosus and its association with disease and work disability. Scand J Rheumatol [Internet]. 2010 [cited 2021 Feb 16];39(1):58–62. Available from: https://pubmed.ncbi.nlm.nih.gov/20132072/
DOI: https://doi.org/10.3109/03009740903124408
Elera-Fitzcarrald C, Fuentes A, González LA, Burgos PI, Alarcón GS, Ugarte-Gil MF. Factors affecting quality of life in patients with systemic lupus erythematosus: important considerations and potential interventions. Expert Rev Clin Immunol [Internet]. 2018;14(11):915–31. Available from: https://doi.org/10.1080/1744666X.2018.1529566
DOI: https://doi.org/10.1080/1744666X.2018.1529566
McElhone K, Abbott J, Shelmerdine J, Bruce IN, Ahmad Y, Gordon C, et al. Development and validation of a disease-specific health-related quality of life measure, the LupusQoL, for adults with systemic lupus erythematosus. Arthritis Care Res [Internet]. 2007 Aug 15 [cited 2021 Feb 16];57(6):972–9. Available from: https://pubmed.ncbi.nlm.nih.gov/17665467/
DOI: https://doi.org/10.1002/art.22881
Yazdany J. Health-related quality of life measurement in adult systemic lupus erythematosus: Lupus Quality of Life (LupusQoL), Systemic Lupus Erythematosus-Specific Quality of Life Questionnaire (SLEQOL), and Systemic Lupus Erythematosus Quality of Life Questionnaire (L-QoL). Arthritis Care Res [Internet]. 2011 Nov [cited 2021 Feb 24];63(SUPPL. 11). Available from: https://pubmed.ncbi.nlm.nih.gov/22588761/
Jolly M, Pickard AS, Block JA, Kumar RB, Mikolaitis RA, Wilke CT, et al. Disease-specific patient reported outcome tools for systemic lupus erythematosus. Semin Arthritis Rheum [Internet]. 2012 Aug [cited 2021 Feb 16];42(1):56–65. Available from: https://pubmed.ncbi.nlm.nih.gov/22480408/
DOI: https://doi.org/10.1016/j.semarthrit.2011.12.005
Jolly M, Garris CP, Mikolaitis RA, Jhingran PM, Dennis G, Wallace DJ, et al. Development and validation of the lupus impact tracker: A patient-completed tool for clinical practice to assess and monitor the impact of systemic lupus erythematosus. Arthritis Care Res [Internet]. 2014 Oct 1 [cited 2021 Feb 23];66(10):1542–50. Available from: https://pubmed.ncbi.nlm.nih.gov/24757021/
Ware JE, Ware J. SF-36 Physical and Mental Health Summary Scales: a User’s Manual Estimation of medical care total expenditures View project [Internet]. 1993 [cited 2021 Feb 16]. Available from: https://www.researchgate.net/publication/292390260
Ware JE, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: Construction of Scales and Preliminary Tests of Reliability and Validity. Med Care [Internet]. 1996 [cited 2021 Feb 23];34(3):220–33. Available from: https://pubmed.ncbi.nlm.nih.gov/8628042/
DOI: https://doi.org/10.1097/00005650-199603000-00003
Webster K, Cella D, Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: Properties, applications, and interpretation [Internet]. Vol. 1, Health and Quality of Life Outcomes. BioMed Central; 2003 [cited 2021 Feb 16]. p. 79. Available from: /pmc/articles/PMC317391/
DOI: https://doi.org/10.1037/t77273-000
Jolly M, Garris CP, Mikolaitis RA, Jhingran PM, Dennis G, Wallace DJ, et al. Development and validation of the lupus impact tracker: A patient-completed tool for clinical practice to assess and monitor the impact of systemic lupus erythematosus. Arthritis Care Res [Internet]. 2014 Oct 1 [cited 2021 Feb 16];66(10):1542–50. Available from: https://pubmed.ncbi.nlm.nih.gov/24757021/
DOI: https://doi.org/10.1002/acr.22349
Yazdany J. Health-related quality of life measurement in adult systemic lupus erythematosus: Lupus Quality of Life (LupusQoL), Systemic Lupus Erythematosus-Specific Quality of Life Questionnaire (SLEQOL), and Systemic Lupus Erythematosus Quality of Life Questionnaire (L-QoL). Arthritis Care Res [Internet]. 2011 Nov [cited 2021 Feb 16];63(SUPPL. 11). Available from: https://pubmed.ncbi.nlm.nih.gov/22588761/
Stoll T, Gordon C, Seifert B, Richardson K, Malik J, Bacon PA, et al. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; Its association with disease activity and damage in patients with systemic lupus erythematosus. J Rheumatol [Internet]. 1997 Aug 1 [cited 2021 Feb 24];24(8):1608–14. Available from: https://europepmc.org/article/med/9263159
Touma Z, Gladman DD, Ibanẽz D, Urowitz MB. Is there an advantage over SF-36 with a quality of life measure that is specific to systemic lupus erythematosus? J Rheumatol [Internet]. 2011 Sep [cited 2021 Feb 24];38(9):1898–905. Available from: https://pubmed.ncbi.nlm.nih.gov/21724700/
DOI: https://doi.org/10.3899/jrheum.110007
Leong KP, Kong KO, Thong BYH, Koh ET, Lian TY, Teh CL, et al. Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQOL). Rheumatology [Internet]. 2005 Oct 1 [cited 2021 Mar 29];44(10):1267–76. Available from: https://pubmed.ncbi.nlm.nih.gov/15797980/
DOI: https://doi.org/10.1093/rheumatology/keh605
Nantes SG, Strand V, Su J, Touma Z. Comparison of the Sensitivity to Change of the 36-Item Short Form Health Survey and the Lupus Quality of Life Measure Using Various Definitions of Minimum Clinically Important Differences in Patients With Active Systemic Lupus Erythematosus. Arthritis Care Res [Internet]. 2018 Jan 1 [cited 2021 Feb 12];70(1):125–33. Available from: http://doi.wiley.com/10.1002/acr.23240
DOI: https://doi.org/10.1002/acr.23240
Corneloup M, Maurier F, Wahl D, Wahl D, Muller G, Aumaitre O, et al. Disease-specific quality of life following a flare in systemic lupus erythematosus: An item response theory analysis of the French EQUAL cohort. Rheumatol (United Kingdom). 2020;59(6):1398–406.
DOI: https://doi.org/10.1093/rheumatology/kez451
Devilliers H, Bonithon-Kopp C, Jolly M. The lupus impact tracker is responsive to changes in clinical activity measured by the systemic lupus erythematosus responder index. Lupus. 2017;26(4):396–402.
DOI: https://doi.org/10.1177/0961203316667494
McElhone K, Abbott J, Sutton C, Mullen M, Lanyon P, Rahman A, et al. Sensitivity to Change and Minimal Important Differences of the LupusQoL in Patients With Systemic Lupus Erythematosus. Arthritis Care Res. 2016;68(10):1505–13.
DOI: https://doi.org/10.1002/acr.22850
Cosatti MA, Muñoz S, Alba P, Helling CA, Roverano S, Sarano J, et al. Multicenter study to assess presenteeism in systemic lupus erythematosus and its relationship with clinical and sociodemographic features. Lupus. 2018;27(1):33–9.
DOI: https://doi.org/10.1177/0961203317701843
Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage [Internet]. 1997 Feb [cited 2021 Feb 24];13(2):63–74. Available from: https://pubmed.ncbi.nlm.nih.gov/9095563/
DOI: https://doi.org/10.1016/S0885-3924(96)00274-6
Elefante E, Tani C, Stagnaro C, Ferro F, Parma A, Carli L, et al. Impact of fatigue on health-related quality of life and illness perception in a monocentric cohort of patients with systemic lupus erythematosus. BMJ Open Sport Exerc Med [Internet]. 2020 Feb 18 [cited 2021 Feb 24];6(1). Available from: https://pubmed.ncbi.nlm.nih.gov/32075876/
DOI: https://doi.org/10.1136/rmdopen-2019-001133
Barbacki A, Petri M, Avina-Zubieta A, Alarcon GS, Bernatsky S. Fatigue measurements in systemic lupus erythematosus. J Rheumatol [Internet]. 2019 Nov 1 [cited 2021 Feb 24];46(11):1470–7. Available from: https://pubmed.ncbi.nlm.nih.gov/30709953/
DOI: https://doi.org/10.3899/jrheum.180831
Krupp LB, Larocca NG, Muir Nash J, Steinberg AD. The fatigue severity scale: Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol [Internet]. 1989 [cited 2021 Feb 23];46(10):1121–3. Available from: https://pubmed.ncbi.nlm.nih.gov/2803071/
DOI: https://doi.org/10.1001/archneur.1989.00520460115022
Kosinski M, Gajria K, Fernandes AW, Cella D. Qualitative validation of the FACIT-Fatigue scale in systemic lupus erythematosus. Lupus [Internet]. 2013 Apr [cited 2021 Feb 24];22(5):422–30. Available from: https://pubmed.ncbi.nlm.nih.gov/23423250/
DOI: https://doi.org/10.1177/0961203313476360
Goligher E, Pouchot J, Brant R, Kherani R, Avina-Zubieta J, Lacaille D, et al. Minimal clinically important difference for 7 measures of fatigue in patients with systemic lupus erythematosus. J Rheumatol. 2008;35.
Louthrenoo W, Kasitanon N, Morand E, Kandane-Rathnayake R. Comparison of performance of specific (SLEQOL) and generic (SF36) health-related quality of life questionnaires and their associations with disease status of systemic lupus erythematosus: A longitudinal study. Arthritis Res Ther [Internet]. 2020 Jan 10 [cited 2021 Feb 12];22(1). Available from: https://pubmed.ncbi.nlm.nih.gov/31924267/
DOI: https://doi.org/10.1186/s13075-020-2095-4
Hersh A. Measures of health-related quality of life in pediatric systemic lupus erythematosus: Childhood Health Assessment Questionnaire (C-HAQ), Child Health Questionnaire (CHQ), Pediatric Quality of Life Inventory Generic Core Module (PedsQL-GC), Pediatric Quality of Life Inventory Rheumatology Module (PedsQL-RM), and Simple Measure of Impact of Lupus Erythematosus in Youngsters (SMILEY). Arthritis Care Res [Internet]. 2011 Nov [cited 2021 Mar 29];63(SUPPL. 11). Available from: https://pubmed.ncbi.nlm.nih.gov/22588765/
DOI: https://doi.org/10.1002/acr.20559
Moorthy LN, Baldino ME, Kurra V, Puwar D, Llanos A, Peterson MGE, et al. Relationship between health-related quality of life, disease activity and disease damage in a prospective international multicenter cohort of childhood onset systemic lupus erythematosus patients. Lupus. 2017;26(3):255–65.
DOI: https://doi.org/10.1177/0961203316659546
Mirbagher L, Gholamrezaei A, Hosseini N, Sayed Bonakdar Z. Sleep quality in women with systemic lupus erythematosus: Contributing factors and effects on health-related quality of life. Int J Rheum Dis [Internet]. 2016 Mar 1 [cited 2021 Feb 12];19(3):305–11. Available from: https://pubmed.ncbi.nlm.nih.gov/24910903/
DOI: https://doi.org/10.1111/1756-185X.12418
Mazzoni D, Cicognani E. Positive and problematic support, stress and quality of life in patients with systemic lupus erythematosus. Anxiety, Stress Coping [Internet]. 2016;29(5):542–51. Available from: http://dx.doi.org/10.1080/10615806.2015.1134785
DOI: https://doi.org/10.1080/10615806.2015.1134785
Yilmaz-Oner S, Oner C, Dogukan FM, Moses TF, Demir K, Tekayev N, et al. Health-related quality of life assessed by LupusQoL questionnaire and SF-36 in Turkish patients with systemic lupus erythematosus. Clin Rheumatol. 2016;35(3):617–22.
DOI: https://doi.org/10.1007/s10067-015-2930-1
Wallace DJ, Hobbs K, Clowse MEB, Petri M, Strand V, Pike M, et al. Long-Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate-to- Severe Systemic Lupus Erythematosus: Results from an Open-Label Extension Study. Arthritis Care Res. 2016;68(4):534–43.
DOI: https://doi.org/10.1002/acr.22694
Mazzoni D, Cicognani E. The Problematic Support Scale: A validation among patients with systemic lupus erythematosus. J Health Psychol. 2016;21(8):1711–7.
DOI: https://doi.org/10.1177/1359105314564435
Hanly JG, O’Keeffe AG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, et al. The frequency and outcome of lupus nephritis: Results from an international inception cohort study. Rheumatol (United Kingdom). 2015;55(2):252–62.
Boström C, Elfving B, Dupré B, Opava CH, Lundberg IE, Jansson E. Effects of a one-year physical activity programme for women with systemic lupus erythematosus - A randomized controlled study. Lupus. 2016;25(6):602–16.
DOI: https://doi.org/10.1177/0961203315622817
Fidler L, Keen KJ, Touma Z, Mittoo S. Impact of pulmonary disease on patient-reported outcomes and patient-performed functional testing in systemic lupus erythematosus. Lupus. 2016;25(9):1004–11.
DOI: https://doi.org/10.1177/0961203316630818
Mahieu MA, Ahn GE, Chmiel JS, Dunlop DD, Helenowski IB, Semanik P, et al. Fatigue, patient reported outcomes, and objective measurement of physical activity in systemic lupus erythematosus. Lupus. 2016;25(11):1190–9.
DOI: https://doi.org/10.1177/0961203316631632
Jolly M, Galicier L, Aumaître O, Francès C, Le Guern V, Lioté F, et al. Quality of life in systemic lupus erythematosus: Description in a cohort of French patients and association with blood hydroxychloroquine levels. Lupus. 2016;25(7):735–40.
DOI: https://doi.org/10.1177/0961203315627200
Wang H, Guo X, Lai J, Wang Q, Tian Z, Liu Y, et al. Predictors of health-related quality of life in patients with systemic lupus erythematosus associated pulmonary arterial hypertension. Clin Exp Rheumatol [Internet]. 2016 Mar 1 [cited 2021 Feb 12];34(2):291–5. Available from: https://europepmc.org/article/med/26941000
Macêdo EA, Appenzeller S, Costallat LTL. Gender differences in systemic lupus erythematosus concerning anxiety, depression and quality of life. Lupus. 2016;25(12):1315–27.
DOI: https://doi.org/10.1177/0961203316638934
Otter SJ, Kumar S, Gow P, Dalbeth N, Corkill M, Rohan M, et al. Patterns of foot complaints in systemic lupus erythematosus: A cross sectional survey. J Foot Ankle Res [Internet]. 2016;9(1):4–11. Available from: http://dx.doi.org/10.1186/s13047-016-0143-8
DOI: https://doi.org/10.1186/s13047-016-0143-8
Oliveira-Santos M, Verani JF de S, Camacho LAB, de Andrade CAF, Ferrante-Silva R, Klumb EM. Effectiveness of pharmaceutical care for drug treatment adherence in patients with systemic lupus erythematosus in Rio de Janeiro, Brazil: Study protocol for a randomized controlled trial. Trials [Internet]. 2016;17(1). Available from: http://dx.doi.org/10.1186/s13063-016-1317-1
DOI: https://doi.org/10.1186/s13063-016-1317-1
Mok C, Chan KL, Ho LY. Association of depressive/anxiety symptoms with quality of life and work ability in patients with systemic lupus erythematosus. Clin Exp Rheumatol [Internet]. 2016 Mar 25 [cited 2021 Feb 12];34(3):389–95. Available from: https://europepmc.org/article/med/27049836
Legge A, Doucette S, Hanly JG. Predictors of organ damage progression and effect on health-related quality of life in systemic lupus erythematosus. J Rheumatol. 2016;43(6):1050–6.
DOI: https://doi.org/10.3899/jrheum.150985
Ramondt S, Tiemensma J, Cameron LD, Broadbent E, Kaptein AA. Drawings of blood cells reveal people’s perception of their blood disorder: A pilot study. PLoS One. 2016;11(4):1–11.
DOI: https://doi.org/10.1371/journal.pone.0154348
Mazzoni D, Cicognani E, Prati G. Health-related quality of life in systemic lupus erythematosus: A longitudinal study on the impact of problematic support and self-efficacy. Lupus. 2017;26(2):125–31.
DOI: https://doi.org/10.1177/0961203316646459
Sebastiani GD, Prevete I, Iuliano A, Minisola G. The importance of an early diagnosis in systemic lupus erythematosus. Isr Med Assoc J. 2016;18(3–4):212–5.
Piga M, Gabba A, Congia M, Figus F, Cauli A, Mathieu A. Predictors of musculoskeletal flares and Jaccoud׳s arthropathy in patients with systemic lupus erythematosus: A 5-year prospective study. Semin Arthritis Rheum [Internet]. 2016;46(2):217–24. Available from: http://dx.doi.org/10.1016/j.semarthrit.2016.04.005
DOI: https://doi.org/10.1016/j.semarthrit.2016.04.005
Williams EM, Lorig K, Glover S, Kamen D, Back S, Merchant A, et al. Intervention to Improve Quality of life for African-American lupus patients (IQAN): Study protocol for a randomized controlled trial of a unique a la carte intervention approach to self-management of lupus in African Americans. BMC Health Serv Res [Internet]. 2016;16(1):1–13. Available from: http://dx.doi.org/10.1186/s12913-016-1580-6
DOI: https://doi.org/10.1186/s12913-016-1580-6
López-Pina JA, Meseguer-Henarejos AB, Gascón-Cánovas JJ, Navarro-Villalba DJ, Sinclair VG, Wallston KA. Measurement properties of the brief resilient coping scale in patients with systemic lupus erythematosus using rasch analysis. Health Qual Life Outcomes [Internet]. 2016;14(1):1–8. Available from: http://dx.doi.org/10.1186/s12955-016-0534-3
DOI: https://doi.org/10.1186/s12955-016-0534-3
Pinto AJ, Miyake CNH, Benatti FB, Silva CA, Sallum AME, Borba E, et al. Reduced Aerobic Capacity and Quality of Life in Physically Inactive Patients With Systemic Lupus Erythematosus With Mild or Inactive Disease. Arthritis Care Res. 2016;68(12):1780–6.
DOI: https://doi.org/10.1002/acr.22905
Machado Escobar MA, Yacuzzi MS, Martinez RN, González Lucero L, Bellomio VI, Santana M, et al. Validation of an Argentine version of Lupus Quality of Life questionnaire. Lupus. 2016;25(14):1615–22.
DOI: https://doi.org/10.1177/0961203316660202
Chen HH, Chen DY, Chen YM, Lai KL. Health-related quality of life and utility: comparison of ankylosing spondylitis, rheumatoid arthritis, and systemic lupus erythematosus patients in Taiwan. Clin Rheumatol [Internet]. 2017;36(1):133–42. Available from: http://dx.doi.org/10.1007/s10067-016-3471-y
DOI: https://doi.org/10.1007/s10067-016-3471-y
Inoue M, Shiozawa K, Yoshihara R, Yamane T, Shima Y, Hirano T, et al. The Japanese LupusPRO: A cross-cultural validation of an outcome measure for lupus. Lupus. 2017;26(8):849–56.
DOI: https://doi.org/10.1177/0961203316682100
Jones JT, Carle AC, Wootton J, Liberio B, Lee J, Schanberg LE, et al. Validation of Patient-Reported Outcomes Measurement Information System Short Forms for Use in Childhood-Onset Systemic Lupus Erythematosus. Arthritis Care Res. 2017 Jan 1;69(1):133–42.
DOI: https://doi.org/10.1002/acr.22927
Antony A, Kandane-Rathnayake RK, Ko T, Boulos D, Hoi AY, Jolly M, et al. Validation of the Lupus Impact Tracker in an Australian patient cohort. Lupus. 2017;26(1):98–105.
DOI: https://doi.org/10.1177/0961203316664593
Brandt JE, Drenkard C, Kan H, Bao G, Dunlop-Thomas C, Pobiner B, et al. External Validation of the Lupus Impact Tracker in a Southeastern US Longitudinal Cohort With Systemic Lupus Erythematosus. Arthritis Care Res. 2017;69(6):842–8.
DOI: https://doi.org/10.1002/acr.23009
Yilmaz-Oner S, Ilhan B, Can M, Alibaz-Oner F, Polat-Korkmaz O, Ozen G, et al. Fatigue in systemic lupus erythematosus: Association with disease activity, quality of life and psychosocial factors. Z Rheumatol. 2017;76(10):913–9.
DOI: https://doi.org/10.1007/s00393-016-0185-0
Calderón J, Flores P, Aguirre JM, Valdivia G, Padilla O, Barra I, et al. Impact of cognitive impairment, depression, disease activity, and disease damage on quality of life in women with systemic lupus erythematosus. Scand J Rheumatol [Internet]. 2017;46(4):273–80. Available from: https://doi.org/10.1080/03009742.2016.1206617
DOI: https://doi.org/10.1080/03009742.2016.1206617
Lai JS, Beaumont JL, Jensen SE, Kaiser K, Van Brunt DL, Kao AH, et al. An evaluation of health-related quality of life in patients with systemic lupus erythematosus using PROMIS and Neuro-QoL. Clin Rheumatol. 2017;36(3):555–62.
DOI: https://doi.org/10.1007/s10067-016-3476-6
Azizoddin DR, Olmstead R, Cost C, Jolly M, Ayeroff J, Racaza G, et al. A multi-group confirmatory factor analyses of the LupusPRO between southern California and Filipino samples of patients with systemic lupus erythematosus. Lupus. 2017;26(9):967–74.
DOI: https://doi.org/10.1177/0961203316686706
Etchegaray-Morales I, Méndez-Martínez S, Jiménez-Hernández C, Mendoza-Pinto C, Alonso-García NE, Montiel-Jarquín A, et al. Factors associated with health-related quality of life in Mexican lupus patients using the LupusQoL. PLoS One. 2017;12(1):1–10.
DOI: https://doi.org/10.1371/journal.pone.0170209
Inoue M, Shiozawa K, Yoshihara R, Yamane T, Shima Y, Hirano T, et al. Predictors of poor sleep quality in patients with systemic lupus erythematosus. Clin Rheumatol. 2017;36(5):1053–62.
DOI: https://doi.org/10.1007/s10067-017-3545-5
Schneider M, Mosca M, Pego-Reigosa JM, Gunnarsson I, Maurel F, Garofano A, et al. Cross-cultural validation of lupus impact tracker in five European clinical practice settings. Rheumatol (United Kingdom). 2017;56(5):818–28.
DOI: https://doi.org/10.1093/rheumatology/kew492
Stummvoll G, Stamm T. The patients’ perspective: living with lupus in Austria. Wien Klin Wochenschr. 2017;129(17–18):593–7.
DOI: https://doi.org/10.1007/s00508-017-1175-1
Chaigne B, Finckh A, Alpizar-Rodriguez D, Courvoisier D, Ribi C, Chizzolini C. Differential impact of systemic lupus erythematosus and rheumatoid arthritis on health-related quality of life. Qual Life Res. 2017;26(7):1767–75.
DOI: https://doi.org/10.1007/s11136-017-1534-4
Chiara T, Linda C, Andrea DS, Lucrezia R, Sabrina V, Rosaria T, et al. Impact of Joint Involvement on Patients Reported Outcomes in Systemic Lupus Erythematosus. Curr Rheumatol Rev [Internet]. 2017 Mar 15 [cited 2021 Feb 12];14(2):188–92. Available from: https://pubmed.ncbi.nlm.nih.gov/28292254/
DOI: https://doi.org/10.2174/1573397113666170314110022
Golder V, Kandane-Rathnayake R, Hoi AYB, Huq M, Louthrenoo W, An Y, et al. Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study. Arthritis Res Ther. 2017;19(1):1–11.
DOI: https://doi.org/10.1186/s13075-017-1256-6
Chaigne B, Chizzolini C, Perneger T, Trendelenburg M, Huynh-Do U, Dayer E, et al. Impact of disease activity on health-related quality of life in systemic lupus erythematosus - a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS). BMC Immunol. 2017;18(1):1–9.
DOI: https://doi.org/10.1186/s12865-017-0200-5
Magro-Checa C, Beaart-Van De Voorde LJJ, Middelkoop HAM, Dane ML, Van Der Wee NJ, Van Buchem MA, et al. Outcomes of neuropsychiatric events in systemic lupus erythematosus based on clinical phenotypes; Prospective data from the Leiden NP SLE cohort. Lupus. 2017;26(5):543–51.
DOI: https://doi.org/10.1177/0961203316689145
Kent T, Davidson A, Newman D, Buck G, D’Cruz D. Burden of illness in systemic lupus erythematosus: Results from a UK patient and carer online survey. Lupus. 2017;26(10):1095–100.
DOI: https://doi.org/10.1177/0961203317698594
Kasturi S, Szymonifka J, Burket JC, Berman JR, Kirou KA, Levine AB, et al. Validity and reliability of patient reported outcomes measurement information system computerized adaptive tests in systemic lupus erythematosus. J Rheumatol. 2017;44(7):1024–31.
DOI: https://doi.org/10.3899/jrheum.161202
Monahan RC, Beaart-Van De Voorde LJJ, Steup-Beekman GM, Magro-Checa C, Huizinga TWJ, Hoekman J, et al. Neuropsychiatric symptoms in systemic lupus erythematosus: Impact on quality of life. Lupus [Internet]. 2017 Oct 1 [cited 2021 Feb 12];26(12):1252–9. Available from: http://journals.sagepub.com/doi/10.1177/0961203317694262
DOI: https://doi.org/10.1177/0961203317694262
Mok CC, Ho LY, Tse SM, Chan KL. Prevalence of remission and its effect on damage and quality of life in Chinese patients with systemic lupus erythematosus. Ann Rheum Dis. 2017;76(8):1420–5.
DOI: https://doi.org/10.1136/annrheumdis-2016-210382
Uzuner S, Sahin S, Durcan G, Adrovic A, Barut K, Kilicoglu AG, et al. The impact of peer victimization and psychological symptoms on quality of life in children and adolescents with systemic lupus erythematosus. Clin Rheumatol. 2017;36(6):1297–304.
DOI: https://doi.org/10.1007/s10067-017-3650-5
Meseguer-Henarejos AB, Gascón-Cánovas JJ, López-Pina JA. Components of quality of life in a sample of patients with lupus: a confirmatory factor analysis and Rasch modeling of the LupusQoL. Clin Rheumatol. 2017;36(8):1789–95.
DOI: https://doi.org/10.1007/s10067-017-3649-y
Duruöz MT, Unal C, Toprak CS, Sezer, Yilmaz F, Ulutatar F, et al. The validity and reliability of Systemic Lupus Erythematosus Quality of Life Questionnaire (L-QoL) in a Turkish population. Lupus. 2017;26(14):1528–33.
DOI: https://doi.org/10.1177/0961203317707063
Shamekhi Z, Amani R, Habibagahi Z, Namjoyan F, Ghadiri A, Saki Malehi A. A Randomized, Double-blind, Placebo-controlled Clinical Trial Examining the Effects of Green Tea Extract on Systemic Lupus Erythematosus Disease Activity and Quality of Life. Phyther Res. 2017;31(7):1063–71.
DOI: https://doi.org/10.1002/ptr.5827
Corrêa JD, Branco LGA, Calderaro DC, Mendonça SMS, Travassos D V., Ferreira GA, et al. Impact of systemic lupus erythematosus on oral health-related quality of life. Lupus. 2018;27(2):283–9.
DOI: https://doi.org/10.1177/0961203317719147
Carnero Contentti E, Genco ND, Hryb JP, Caspi M, Chiganer E, Di Pace JL, et al. Impact of multiple sclerosis on quality of life: Comparison with systemic lupus erythematosus. Clin Neurol Neurosurg [Internet]. 2017;163(August):149–55. Available from: http://dx.doi.org/10.1016/j.clineuro.2017.10.032
DOI: https://doi.org/10.1016/j.clineuro.2017.10.032
Margiotta DPE, Basta F, Dolcini G, Batani V, Navarini L, Afeltra A. The relation between, metabolic syndrome and quality of life in patients with Systemic Lupus Erythematosus. PLoS One. 2017;12(11):1–17.
DOI: https://doi.org/10.1371/journal.pone.0187645
Muhammed H, Goyal M, Lal V, Singh S, Dhir V. Neuropsychiatric manifestations are not uncommon in Indian lupus patients and negatively affect quality of life. Lupus. 2018;27(4):688–93.
DOI: https://doi.org/10.1177/0961203317747720
Hersh AO, Case SM, Son MB. Predictors of disability in a childhood-onset systemic lupus erythematosus cohort: results from the CARRA Legacy Registry. Lupus. 2018;27(3):494–500.
DOI: https://doi.org/10.1177/0961203317747713
Piga M, Congia M, Gabba A, Figus F, Floris A, Mathieu A, et al. Musculoskeletal manifestations as determinants of quality of life impairment in patients with systemic lupus erythematosus. Lupus. 2018;27(2):190–8.
DOI: https://doi.org/10.1177/0961203317716319
Iudici M, Pantano I, Fasano S, Pierro L, Charlier B, Pingeon M, et al. Health status and concomitant prescription of immunosuppressants are risk factors for hydroxychloroquine non-adherence in systemic lupus patients with prolonged inactive disease. Lupus. 2018;27(2):265–72.
DOI: https://doi.org/10.1177/0961203317717631
Donnelly C, Cunningham N, Jones JT, Ji L, Brunner HI, Kashikar-Zuck S. Fatigue and depression predict reduced health-related quality of life in childhood-onset lupus. Lupus [Internet]. 2018 Jan 1 [cited 2021 Feb 12];27(1):124–33. Available from: http://journals.sagepub.com/doi/10.1177/0961203317716317
DOI: https://doi.org/10.1177/0961203317716317
Zeng F, Xu Q, Liu D, Luo H, Zhou YO, Ning W, et al. Relatives’ quality of life and psychological disturbance: A new concern of SLE management. Clin Rheumatol. 2018;37(1):67–73.
DOI: https://doi.org/10.1007/s10067-017-3743-1
Jolly M, Toloza S, Goker B, Clarke AE, Navarra S V., Wallace D, et al. Disease-specific quality of life in patients with lupus nephritis. Lupus. 2018;27(2):257–64.
DOI: https://doi.org/10.1177/0961203317717082
Golder V, Ooi JJY, Antony AS, Ko T, Morton S, Kandane-Rathnayake R, et al. Discordance of patient and physician health status concerns in systemic lupus erythematosus. Lupus. 2018;27(3):501–6.
DOI: https://doi.org/10.1177/0961203317722412
Baba S, Katsumata Y, Okamoto Y, Kawaguchi Y, Hanaoka M, Kawasumi H, et al. Reliability of the SF-36 in Japanese patients with systemic lupus erythematosus and its associations with disease activity and damage: a two-consecutive year prospective study. Lupus. 2018;27(3):407–16.
DOI: https://doi.org/10.1177/0961203317725586
Lee JW, Kang JH, Lee KE, Park DJ, Kang SW, Kwok SK, et al. Effects of risk factors for and components of metabolic syndrome on the quality of life of patients with systemic lupus erythematosus: a structural equation modeling approach. Qual Life Res. 2018;27(1):105–13.
DOI: https://doi.org/10.1007/s11136-017-1689-z
Azizoddin DR, Weinberg S, Gandhi N, Arora S, Block JA, Sequeira W, et al. Validation of the LupusPRO version 1.8: an update to a disease-specific patient-reported outcome tool for systemic lupus erythematosus. Lupus. 2018;27(5):728–37.
DOI: https://doi.org/10.1177/0961203317739128
Jiang HZ, Lin ZG, Li HJ, Qing-Du, Wei-Tian, Wang SY, et al. The Chinese version of the SLEQOL is a reliable assessment of health-related quality of life in han chinese patients with systemic lupus erythematosus. Clin Rheumatol. 2018;37(1):151–60.
DOI: https://doi.org/10.1007/s10067-017-3910-4
Elera-Fitzcarrald C, Alva M, Gamboa-Cardenas R, Mora-Trujillo CS, Zevallos F, García-Poma A, et al. Factors associated with health-related quality of life in Peruvian patients with systemic lupus erythematosus. Lupus. 2018;27(6):913–9.
DOI: https://doi.org/10.1177/0961203317751062
Azizoddin DR, Gandhi N, Weinberg S, Sengupta M, Nicassio PM, Jolly M. Fatigue in systemic lupus: the role of disease activity and its correlates. Lupus. 2019;28(2):163–73.
DOI: https://doi.org/10.1177/0961203318817826
Tsang-A-Sjoe MWP, Bultink IEM, Heslinga M, Van Tuyl LH, Van Vollenhoven RF, Voskuyl AE. The relationship between remission and health-related quality of life in a cohort of SLE patients. Rheumatol (United Kingdom) [Internet]. 2019 Apr 1 [cited 2021 Feb 12];58(4):628–35. Available from: https://pubmed.ncbi.nlm.nih.gov/30517706/
DOI: https://doi.org/10.1093/rheumatology/key349
Pereira e Silva R, Romão VC, Neves M, Garcia R, Oliveira S, Brites J, et al. Overactive bladder symptom bother and health-related quality of life in patients with systemic lupus erythematosus and primary Sjögren syndrome. Lupus. 2019;28(1):27–33.
DOI: https://doi.org/10.1177/0961203318811605
Strand V, Berry P, Lin X, Asukai Y, Punwaney R, Ramachandran S. Long-Term Impact of Belimumab on Health-Related Quality of Life and Fatigue in Patients With Systemic Lupus Erythematosus: Six Years of Treatment. Arthritis Care Res. 2019;71(6):829–38.
DOI: https://doi.org/10.1002/acr.23788
Wang H, Wang Q, Tian Z, Guo X, Lai J, Li M, et al. Right Ventricular Function is Associated With Quality of Life in Patients With Systemic Lupus Erythematosus Associated Pulmonary Arterial Hypertension. Hear Lung Circ [Internet]. 2019;28(11):1655–63. Available from: https://doi.org/10.1016/j.hlc.2018.09.002
DOI: https://doi.org/10.1016/j.hlc.2018.09.002
Tarazi M, Gaffney RG, Pearson D, Kushner CJ, Werth VP. Fatigue in systemic lupus erythematosus and other autoimmune skin diseases. Br J Dermatol. 2019;180(6):1468–72.
DOI: https://doi.org/10.1111/bjd.17257
Groot N, Shaikhani D, Teng YKO, de Leeuw K, Bijl M, Dolhain RJEM, et al. Long-Term Clinical Outcomes in a Cohort of Adults With Childhood-Onset Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019;71(2):290–301.
DOI: https://doi.org/10.1002/art.40697
Xie X, Song Y, Yang H, Nie A, Chen H, Li J ping. Effects of transitional care on self-care, readmission rates, and quality of life in adult patients with systemic lupus erythematosus: A randomized controlled trial. Arthritis Res Ther. 2018;20(1):1–8.
DOI: https://doi.org/10.1186/s13075-018-1670-4
Parodis I, Lopez Benavides AH, Zickert A, Pettersson S, Möller S, Welin Henriksson E, et al. The Impact of Belimumab and Rituximab on Health-Related Quality of Life in Patients With Systemic Lupus Erythematosus. Vol. 71, Arthritis Care and Research. 2019. 811–821 p.
DOI: https://doi.org/10.1002/acr.23718
Jolly M, Sequeira W, Block JA, Toloza S, Bertoli A, Blazevic I, et al. Sex Differences in Quality of Life in Patients With Systemic Lupus Erythematosus. Arthritis Care Res. 2019;71(12):1647–52.
DOI: https://doi.org/10.1002/acr.23588
Figueiredo-Braga M, Cornaby C, Bernardes M, Figueiredo M, Dos Santos Mesquita C, Costa L, et al. Correlation between physical markers and psychiatric health in a Portuguese systemic lupus erythematosus cohort: The role of suffering in chronic autoimmune disease. PLoS One. 2018;13(4):1–16.
DOI: https://doi.org/10.1371/journal.pone.0195579
Waldheim E, Ajeganova S, Bergman S, Frostegård J, Welin E. Variation in pain related to systemic lupus erythematosus (SLE): a 7-year follow-up study. Clin Rheumatol. 2018;37(7):1825–34.
DOI: https://doi.org/10.1007/s10067-018-4079-1
Pascual-Ramos V, Contreras-Yáñez I, Valencia-Quiñones KR, Romero-Díaz J. Rheumatoid arthritis patients achieved better quality of life than systemic lupus erythematosus patients at sustained remission. Clin Exp Rheumatol. 2018;36(4):619–26.
DOI: https://doi.org/10.1136/annrheumdis-2017-eular.1187
Merrill JT, Shanahan WR, Scheinberg M, Kalunian KC, Wofsy D, Martin RS. Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): Results from a randomised, double-blind, placebo-controlled trial. Ann Rheum Dis. 2018;77(6):883–9.
DOI: https://doi.org/10.1136/annrheumdis-2018-213032
Margiotta DPE, Basta F, Dolcini G, Batani V, Vullo M Lo, Vernuccio A, et al. Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus. PLoS One. 2018;13(3):1–16.
DOI: https://doi.org/10.1371/journal.pone.0193728
Kasturi S, Szymonifka J, Burket JC, Berman JR, Kirou KA, Levine AB, et al. Feasibility, validity, and reliability of the 10-item patient reported outcomes measurement information system global health short form in outpatients with systemic lupus erythematosus. J Rheumatol. 2018;45(3):397–404.
DOI: https://doi.org/10.3899/jrheum.170590
Zhao Q, Chen H, Yan H, He Y, Zhu L, Fu WT, et al. The correlations of psychological status, quality of life, self-esteem, social support and body image disturbance in Chinese patients with Systemic Lupus Erythematosus. Psychol Heal Med [Internet]. 2018;23(7):779–87. Available from: https://doi.org/10.1080/13548506.2018.1434214
DOI: https://doi.org/10.1080/13548506.2018.1434214
Nowicka-Sauer K, Hajduk A, Kujawska-Danecka H, Banaszkiewicz D, Smoleńska, Czuszyńska Z, et al. Illness perception is significantly determined by depression and anxiety in systemic lupus erythematosus. Lupus. 2018;27(3):454–60.
DOI: https://doi.org/10.1177/0961203317751858
Aziz MM, Galal MAA, Elzohri MH, El-Nouby F, Leong KP. Cross-cultural adaptation and validation of Systemic Lupus Erythematosus Quality of Life questionnaire into Arabic. Lupus. 2018;27(5):780–7.
DOI: https://doi.org/10.1177/0961203317747714
Seguier J, Jouve E, Bobot M, Whalen E, Dussol B, Gentile S, et al. Paradoxical association between blood modular interferon signatures and quality of life in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2020;59(8):1975–83.
DOI: https://doi.org/10.1093/rheumatology/kez541
Margiotta DPE, Fasano S, Basta F, Pierro L, Riccardi A, Navarini L, et al. The association between duration of remission, fatigue, depression and health-related quality of life in Italian patients with systemic lupus erythematosus. Lupus. 2019;28(14):1705–11.
DOI: https://doi.org/10.1177/0961203319884651
Jolly M, Annapureddy N, Arnaud L, Devilliers H. Changes in quality of life in relation to disease activity in systemic lupus erythematosus: post-hoc analysis of the BLISS-52 Trial. Lupus. 2019;28(14):1628–39.
DOI: https://doi.org/10.1177/0961203319886065
Pinto B, Jolly M, Dhooria A, Grover S, Raj JM, Devilliers H, et al. Hindi LupusPRO: cross cultural validation of disease specific patient reported outcome measure of lupus. Lupus. 2019;28(13):1534–40.
DOI: https://doi.org/10.1177/0961203319880340
Pinto B, Grover S, Dhooria A, Rathi M, Sharma A. Sexual functioning and its correlates in premenopausal married Indian women with systemic lupus erythematosus. Int J Rheum Dis. 2019;22(10):1814–9.
DOI: https://doi.org/10.1111/1756-185X.13675
Gholizadeh S, Azizoddin DR, Mills SD, Zamora G, Potemra HMK, Hirz AE, et al. Body image mediates the impact of pain on depressive symptoms in patients with systemic lupus erythematosus. Lupus. 2019;28(9):1148–53.
DOI: https://doi.org/10.1177/0961203319861675
Wu ML, Tsai JC, Yu KH, Chen JJ. Effects of physical activity counselling in women with systemic lupus erythematosus: A randomized controlled trial. Int J Nurs Pract. 2019;25(5):1–11.
DOI: https://doi.org/10.1111/ijn.12770
Živković V, MitićII B, Stamenković B, Stojanović S, Dinić BR, Stojanović M, et al. Analysis on the risk factors for organ damage in patients with systemic lupus erythematosus: A cross-sectional single-center experience. Sao Paulo Med J [Internet]. 2019 Mar 1 [cited 2021 Feb 12];137(2):155–61. Available from: https://pubmed.ncbi.nlm.nih.gov/31314876/
DOI: https://doi.org/10.1590/1516-3180.2018.0258060219
Kasturi S, Szymonifka J, Berman JR, Kirou KA, Levine AB, Sammaritano LR, et al. Responsiveness of the Patient-Reported Outcomes Measurement Information System Global Health Short Form in Outpatients With Systemic Lupus Erythematosus. Arthritis Care Res. 2020;72(9):1282–8.
DOI: https://doi.org/10.1002/acr.24026
Poomsalood N, Narongroeknawin P, Chaiamnuay S, Asavatanabodee P, Pakchotanon R. Prolonged clinical remission and low disease activity statuses are associated with better quality of life in systemic lupus erythematosus. Lupus. 2019;28(10):1189–96.
DOI: https://doi.org/10.1177/0961203319862614
Ugarte-Gil MF, Pons-Estel GJ, Vila LM, McGwin G, Alarcón GS. Time in remission and low disease activity state (LDAS) are associated with a better quality of life in patients with systemic lupus erythematosus: Results from LUMINA (LXXIX), a multiethnic, multicentre US cohort. RMD Open. 2019;5(1):1–4.
DOI: https://doi.org/10.1136/rmdopen-2019-000955
Ugarte-Gil MF, Gamboa-Cárdenas R V., Reátegui-Sokolova C, Medina-Chinchón M, Zevallos F, Elera-Fitzcarrald C, et al. Better Health-Related Quality of Life in Systemic Lupus Erythematosus Predicted by Low Disease Activity State/Remission: Data From the Peruvian Almenara Lupus Cohort. Arthritis Care Res. 2020;72(8):1159–62.
DOI: https://doi.org/10.1002/acr.24009
Margiotta DPE, Fasano S, Basta F, Pierro L, Riccardi A, Navarini L, et al. Clinical features of patients with systemic lupus erythematosus according to health-related quality of life, entity of pain, fatigue and depression: A cluster analysis. Clin Exp Rheumatol. 2019;37(4):535–9.
Goswami RP, Chatterjee R, Ghosh P, Sircar G, Ghosh A. Quality of life among female patients with systemic lupus erythematosus in remission. Rheumatol Int [Internet]. 2019;39(8):1351–8. Available from: https://doi.org/10.1007/s00296-019-04329-1
DOI: https://doi.org/10.1007/s00296-019-04329-1
Feng C, He Q, Wu Y, Hu X, Wu J, He X, et al. Psychometric properties of fatigue severity scale in Chinese systemic lupus erythematosus patients. Health Qual Life Outcomes. 2019;17(1):15–20.
DOI: https://doi.org/10.1186/s12955-019-1141-x
Abu Bakar F, Shaharir SS, Mohd R, Kamaruzaman L, Mohamed Said MS. Work disability in a multi-ethnic Malaysian systemic lupus erythematosus cohort: A cross-sectional study. Int J Rheum Dis. 2019;22(6):1002–7.
DOI: https://doi.org/10.1111/1756-185X.13572
Horisberger A, Courvoisier D, Ribi C. The Fatigue Assessment Scale as a simple and reliable tool in systemic lupus erythematosus: A cross-sectional study. Arthritis Res Ther. 2019;21(1):1–8.
DOI: https://doi.org/10.1186/s13075-019-1864-4
Román Ivorra JA, Fernández-Llanio-Comella N, San-Martín-Álvarez A, Vela-Casasempere P, Saurí-Ferrer I, González-de-Julián S, et al. Health-related quality of life in patients with systemic lupus erythematosus: a Spanish study based on patient reports. Clin Rheumatol. 2019;38(7):1857–64.
DOI: https://doi.org/10.1007/s10067-019-04485-6
Gavilán-Carrera B, Da Silva JG, Vargas-Hitos JA, Sabio JM, Morillas-de-Laguno P, Rios-Fernández R, et al. Association of physical fitness components and health-related quality of life in women with systemic lupus erythematosus with mild disease activity. PLoS One. 2019;14(2):1–17.
DOI: https://doi.org/10.1371/journal.pone.0212436
Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, et al. Evaluating the Properties of a Frailty Index and Its Association With Mortality Risk Among Patients With Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019;71(8):1297–307.
DOI: https://doi.org/10.1002/art.40859
Park EH, Strand V, Oh YJ, Song YW, Lee EB. Health-related quality of life in systemic sclerosis compared with other rheumatic diseases: A cross-sectional study. Arthritis Res Ther. 2019;21:1–10.
DOI: https://doi.org/10.1186/s13075-019-1842-x
Conceição CTM, Meinão IM, Bombana JA, Sato EI. Psychoanalytic psychotherapy improves quality of life, depression, anxiety and coping in patients with systemic lupus erythematosus: a controlled randomized clinical trial. Adv Rheumatol (London, England). 2019;59(1):4.
DOI: https://doi.org/10.1186/s42358-019-0047-y
Castellano Rioja E, Valero-Moreno S, del Carmen Giménez-Espert M, Prado-Gascó V. The relations of quality of life in patients with lupus erythematosus: Regression models versus qualitative comparative analysis. J Adv Nurs. 2019;75(7):1484–92.
DOI: https://doi.org/10.1111/jan.13957
Delis PC. Uncertainty and Quality of Life in Systemic Lupus Erythematosus: A Cross-sectional Study. Rehabil Nurs. 2019;44(1):2–10.
DOI: https://doi.org/10.1097/rnj.0000000000000118
Katz P, Wan GJ, Daly P, Topf L, Connolly-Strong E, Bostic R, et al. Patient-reported flare frequency is associated with diminished quality of life and family role functioning in systemic lupus erythematosus. Qual Life Res [Internet]. 2020;29(12):3251–61. Available from: https://doi.org/10.1007/s11136-020-02572-9
DOI: https://doi.org/10.1007/s11136-020-02572-9
Ratanasiripong NT, Ratanasiripong P. Predictive factors of quality of life among systemic lupus erythematosus patients in Thailand: a web-based cross-sectional study. Qual Life Res [Internet]. 2020;29(9):2415–23. Available from: https://doi.org/10.1007/s11136-020-02494-6
DOI: https://doi.org/10.1007/s11136-020-02494-6
Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, et al. Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index. Arthritis Rheumatol. 2020;72(4):658–66.
DOI: https://doi.org/10.1002/art.41144
Revenson TA, Schiaffino KM, Deborah Majerovitz S, Gibofsky A. Social support as a double-edged sword: The relation of positive and problematic support to depression among rheumatoid arthritis patients. Soc Sci Med [Internet]. 1991 [cited 2021 Feb 16];33(7):807–13. Available from: https://pubmed.ncbi.nlm.nih.gov/1948172/
DOI: https://doi.org/10.1016/0277-9536(91)90385-P
Varni JW, Burwinkle TM, Seid M, Skarr D. The PedsQLTM* 4.0 as a pediatric population health measure: Feasibility, reliability, and validity. Ambul Pediatr [Internet]. 2003 [cited 2021 Feb 23];3(6):329–41. Available from: https://pubmed.ncbi.nlm.nih.gov/14616041/
DOI: https://doi.org/10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2
Rothrock NE, Hays RD, Spritzer K, Yount SE, Riley W, Cella D. Relative to the general US population, chronic diseases are associated with poorer health-related quality of life as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS). J Clin Epidemiol [Internet]. 2010 Nov [cited 2021 Feb 23];63(11):1195–204. Available from: https://pubmed.ncbi.nlm.nih.gov/20688471/
DOI: https://doi.org/10.1016/j.jclinepi.2010.04.012
Moorthy LN, Peterson MGE, Baratelli M, Harrison MJ, Onel KB, Chalom EC, et al. Multicenter validation of a new quality of life measure in pediatric lupus. Arthritis Care Res [Internet]. 2007 Oct 15 [cited 2021 Feb 23];57(7):1165–73. Available from: https://pubmed.ncbi.nlm.nih.gov/17907234/
DOI: https://doi.org/10.1002/art.22988
Meiorin S, Pistorio A, Ravelli A, Iusan SM, Filocamo G, Trail L, et al. Validation of the Childhood Health Assessment Questionnaire in active juvenile systemic lupus erythematosus. Arthritis Rheum [Internet]. 2008 Aug 15 [cited 2021 Feb 23];59(8):1112–9. Available from: http://doi.wiley.com/10.1002/art.23912
DOI: https://doi.org/10.1002/art.23912
de Raaij EJ, Schröder C, Maissan FJ, Pool JJ, Wittink H. Cross-cultural adaptation and measurement properties of the Brief Illness Perception Questionnaire-Dutch Language Version. Man Ther [Internet]. 2012 Aug [cited 2021 Feb 23];17(4):330–5. Available from: https://pubmed.ncbi.nlm.nih.gov/22483222/
DOI: https://doi.org/10.1016/j.math.2012.03.001
Williams EM, Ortiz K, Flournoy-Floyd M, Bruner L, Kamen D. Systemic lupus erythematosus observations of travel burden: A qualitative inquiry. Int J Rheum Dis [Internet]. 2015 Sep 1 [cited 2021 Feb 23];18(7):751–60. Available from: https://pubmed.ncbi.nlm.nih.gov/26176174/
DOI: https://doi.org/10.1111/1756-185X.12614
Elera-Fitzcarrald C, Vega K, Gamboa-Cárdenas R V., Zúñiga K, Zevallos F, Reátegui-Sokolova C, et al. Reliability of Visual Analog Scale and Numeric Rating Scale for the Assessment of Disease Activity in Systemic Lupus Erythematosus. JCR J Clin Rheumatol [Internet]. 2020 Oct 1 [cited 2021 Feb 23];26(7S):S170–3. Available from: https://journals.lww.com/10.1097/RHU.0000000000001274
DOI: https://doi.org/10.1097/RHU.0000000000001274
Beiza BL, Henke CJ, Yeun E, Epstein W V., Gauss CI. Correlates of fatigue in older adults with rheumatoid arthritis. Nurs Res. 1993;42(2):93–9.
DOI: https://doi.org/10.1097/00006199-199303000-00006
Wang S, Wu B, Zhu L, Leng L, Bucala R, Lu L. Construct and Criterion Validity of the Euro Qol-5D in Patients with Systemic Lupus Erythematosus. Kuwana M, editor. PLoS One [Internet]. 2014 Jun 3 [cited 2021 Feb 23];9(6):e98883. Available from: https://dx.plos.org/10.1371/journal.pone.0098883
DOI: https://doi.org/10.1371/journal.pone.0098883
Maneeton B, Maneeton N, Louthrenoo W. Cognitive deficit in patients with systemic lupus erythematosus. Asian Pacific J Allergy Immunol [Internet]. 2010 Mar 1 [cited 2021 Feb 23];28(1):77–83. Available from: https://europepmc.org/article/med/20527520
Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psychiatry Res [Internet]. 1989 [cited 2021 Feb 23];28(2):193–213. Available from: https://pubmed.ncbi.nlm.nih.gov/2748771/
DOI: https://doi.org/10.1016/0165-1781(89)90047-4
Ferrucci L, Koh C, Bandinelli S, Guralnik JM. Measuring disability. In: Practice of Geriatrics. Elsevier; 2007. p. 255–70.
DOI: https://doi.org/10.1016/B978-1-4160-2261-9.50024-0
Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand [Internet]. 1983 [cited 2021 Feb 23];67(6):361–70. Available from: https://pubmed.ncbi.nlm.nih.gov/6880820/
DOI: https://doi.org/10.1111/j.1600-0447.1983.tb09716.x
Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385–96.
DOI: https://doi.org/10.2307/2136404
Hunt SM, McKenna SP, McEwen J, Williams J, Papp E. The Nottingham health profile: Subjective health status and medical consultations. Soc Sci Med Part A Med Psychol Med [Internet]. 1981 [cited 2021 Feb 23];15(3 PART 1):221–9. Available from: https://pubmed.ncbi.nlm.nih.gov/6973203/
DOI: https://doi.org/10.1016/0271-7123(81)90005-5
Slade GD, Spencer AJ. Development and evaluation of the Oral Health Impact Profile. Community Dent Health [Internet]. 1994 Mar 1 [cited 2021 Feb 23];11(1):3–11. Available from: http://europepmc.org/article/med/8193981
Rosch PJ. Insomnia, psychological assessment and management, Charles M. Morin, Guilford Press, New York, 1993. No. of pages: 238. Price: $26.95. Stress Med [Internet]. 1994 Jan 1 [cited 2021 Feb 23];10(1):69–70. Available from: http://doi.wiley.com/10.1002/smi.2460100113
DOI: https://doi.org/10.1002/smi.2460100113
Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med [Internet]. 2001 [cited 2021 Feb 23];16(9):606–13. Available from: https://pubmed.ncbi.nlm.nih.gov/11556941/
DOI: https://doi.org/10.1046/j.1525-1497.2001.016009606.x
Yazdany J. Health-related quality of life measurement in adult systemic lupus erythematosus: Lupus Quality of Life (LupusQoL), Systemic Lupus Erythematosus-Specific Quality of Life Questionnaire (SLEQOL), and Systemic Lupus Erythematosus Quality of Life Questionnaire (L-QoL). Arthritis Care Res [Internet]. 2011 Nov [cited 2021 Feb 23];63(SUPPL. 11). Available from: https://pubmed.ncbi.nlm.nih.gov/22588761/
DOI: https://doi.org/10.1002/acr.20636
Hassett AL, Li T, Radvanski DC, Savage S V., Buyske S, Schiff SA, et al. Assessment of health-related family role functioning in systemic lupus erythematosus: Preliminary validation of a new measure. Arthritis Care Res (Hoboken) [Internet]. 2012 Sep 1 [cited 2021 Feb 23];64(9):1341–8. Available from: http://doi.wiley.com/10.1002/acr.21676
DOI: https://doi.org/10.1002/acr.21676
Hennessy CH, Moriarty DG, Zack MM, Scherr PA, Brackbill R. Measuring health-related quality of life for public health surveillance [Internet]. Vol. 109, Public Health Reports. SAGE Publications; 1994 [cited 2021 Feb 23]. p. 665–72. Available from: /pmc/articles/PMC1403555/?report=abstract
Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med [Internet]. 2006 May 22 [cited 2021 Feb 24];166(10):1092–7. Available from: https://pubmed.ncbi.nlm.nih.gov/16717171/
DOI: https://doi.org/10.1001/archinte.166.10.1092
Ferreira LN, Ferreira PL, Pereira LN, Rowen D, Brazier JE. Exploring the consistency of the SF-6D. Value Heal [Internet]. 2013 Sep [cited 2021 Feb 24];16(6):1023–31. Available from: https://pubmed.ncbi.nlm.nih.gov/24041352/
DOI: https://doi.org/10.1016/j.jval.2013.06.018
Castellano Rioja E. Calidad de vida en pacientes con lupus eritematoso. Nueva escala de valoración. 2015 [cited 2021 Feb 24]; Available from: https://dialnet.unirioja.es/servlet/tesis?codigo=158963&info=resumen&idioma=SPA
Coyne KS, Thompson CL, Lai JS, Sexton CC. An overactive bladder symptom and health-related quality of life short-form: Validation of the OAB-q SF. Neurourol Urodyn [Internet]. 2015 Mar 1 [cited 2021 Feb 24];34(3):255–63. Available from: https://pubmed.ncbi.nlm.nih.gov/25783168/
DOI: https://doi.org/10.1002/nau.22559
Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, et al. Development of a fatigue scale. J Psychosom Res [Internet]. 1993 [cited 2021 Feb 24];37(2):147–53. Available from: https://pubmed.ncbi.nlm.nih.gov/8463991/
DOI: https://doi.org/10.1016/0022-3999(93)90081-P
How to Cite
Radin, M., El Hasbani, G., Barinotti, A., Roccatello, D., Uthman, I., Taher, A., & Sciascia, S. (2022). Quality of life measures in systemic lupus erythematosus: a systematic review. Reumatismo, 73(4). https://doi.org/10.4081/reumatismo.2021.1447
Copyright (c) 2021 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Similar Articles
- N.J. Mchugh, E.R. Soriano, CONVENTIONAL THERAPY OF PSORIATIC ARTHRITIS: EVIDENCE-BASED REVIEW , Reumatismo: Vol. 59 No. s1 (2007)
- H. Marotta, R. Montisci, F. Tiso, S. Pontarollo, M. Rizzo, F. Tona, S. Iliceto, F. Cozzi, Two-years therapy with bosentan of pulmonary arterial hypertension related to connective tissue diseases , Reumatismo: Vol. 59 No. 4 (2007)
- R. Herrera-Esparza, E. Avalos-Diaz, Infliximab treatment in a case of rheumatoid scleromalacia perforans , Reumatismo: Vol. 61 No. 3 (2009)
- A.A. Younis, Urticarial vasculitis as an initial manifestation of colonic carcinoma: a case report and review of the literature , Reumatismo: Vol. 70 No. 4 (2018)
- N. Belfeki, A. Strazzulla, M. Picque, S. Diamantis, Extreme hyperferritinemia: etiological spectrum and impact on prognosis , Reumatismo: Vol. 71 No. 4 (2019)
- B. Maranini, G. Ciancio, R. Cultrera, M. Govoni, Herpes zoster infection following mRNA COVID-19 vaccine in a patient with ankylosing spondylitis , Reumatismo: Vol. 73 No. 3 (2021)
- B. Joob, V. Wiwanitkit, Comment to: Disseminated cutaneous herpes simplex, COVID-19 vaccination and rheumatoid arthritis patient: a case report and review , Reumatismo: Vol. 74 No. 3 (2022)
- C. Rothschild, B. Rothschild, I. Hershkovitz, Clues to recognition of kidney disease in archeologic record: characteristics and occurrence of leontiasis ossea , Reumatismo: Vol. 54 No. 2 (2002)
- N. Malavolta, M. Frigato, R. Mulè, C. Ripamonti, Femoral neck morphology differentiates femoral neck from vertebral osteoporotic fracture , Reumatismo: Vol. 55 No. 2 (2003)
- P. Marson, G. Zanchin, C. Stefanutti, Some historical considerations on the inflammatory theory of atherosclerosis , Reumatismo: Vol. 56 No. 3 (2004)
<< < 45 46 47 48 49 50 51 52 53 54 > >>
You may also start an advanced similarity search for this article.
